Gear Up for Universal Health Services (UHS) Q4 Earnings: Wall Street Estimates for Key Metrics
Werte in diesem Artikel
Analysts on Wall Street project that Universal Health Services (UHS) will announce quarterly earnings of $4.19 per share in its forthcoming report, representing an increase of 33.9% year over year. Revenues are projected to reach $3.99 billion, increasing 7.9% from the same quarter last year.The current level reflects no revision in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.Before a company reveals its earnings, it is vital to take into account any changes in earnings projections. These revisions play a pivotal role in predicting the possible reactions of investors toward the stock. Multiple empirical studies have consistently shown a strong association between trends in earnings estimates and the short-term price movements of a stock.While investors typically use consensus earnings and revenue estimates as indicators of quarterly business performance, exploring analysts' projections for specific key metrics can offer valuable insights.With that in mind, let's delve into the average projections of some Universal Health Services metrics that are commonly tracked and projected by analysts on Wall Street.Based on the collective assessment of analysts, 'Net Revenues- Acute care hospital services' should arrive at $2.26 billion. The estimate indicates a change of +8.2% from the prior-year quarter.Analysts' assessment points toward 'Net Revenues- Behavioral health services' reaching $1.74 billion. The estimate indicates a year-over-year change of +7.6%.The average prediction of analysts places 'Operating Income- Behavioral Health Care Services' at $329.70 million. Compared to the present estimate, the company reported $291.43 million in the same quarter last year.Analysts expect 'Operating Income- Acute Care Hospital Services' to come in at $198.43 million. The estimate compares to the year-ago value of $144.34 million.View all Key Company Metrics for Universal Health Services here>>>Shares of Universal Health Services have experienced a change of -3.1% in the past month compared to the -0.5% move of the Zacks S&P 500 composite. With a Zacks Rank #4 (Sell), UHS is expected to underperform the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>Just Released: Zacks Top 10 Stocks for 2025Hurry – you can still get in early on our 10 top tickers for 2025. Handpicked by Zacks Director of Research Sheraz Mian, this portfolio has been stunningly and consistently successful. From inception in 2012 through November, 2024, the Zacks Top 10 Stocks gained +2,112.6%, more than QUADRUPLING the S&P 500’s +475.6%. Sheraz has combed through 4,400 companies covered by the Zacks Rank and handpicked the best 10 to buy and hold in 2025. You can still be among the first to see these just-released stocks with enormous potential. See New Top 10 Stocks >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Universal Health Services, Inc. (UHS): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Ausgewählte Hebelprodukte auf Q4
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Q4
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Universal Health Services Inc.
Analysen zu Universal Health Services Inc.
Datum | Rating | Analyst | |
---|---|---|---|
03.01.2019 | Universal Health Services Buy | Deutsche Bank AG | |
20.10.2017 | Universal Health Services Outperform | BMO Capital Markets | |
27.04.2017 | Universal Health Services Outperform | RBC Capital Markets | |
05.04.2017 | Universal Health Services Buy | Deutsche Bank AG | |
27.03.2017 | Universal Health Services Buy | Mizuho |
Datum | Rating | Analyst | |
---|---|---|---|
03.01.2019 | Universal Health Services Buy | Deutsche Bank AG | |
20.10.2017 | Universal Health Services Outperform | BMO Capital Markets | |
27.04.2017 | Universal Health Services Outperform | RBC Capital Markets | |
05.04.2017 | Universal Health Services Buy | Deutsche Bank AG | |
27.03.2017 | Universal Health Services Buy | Mizuho |
Datum | Rating | Analyst | |
---|---|---|---|
27.02.2017 | Universal Health Services Neutral | Mizuho | |
09.11.2016 | Universal Health Services Neutral | Mizuho | |
21.04.2016 | Universal Health Services Hold | Standpoint Research | |
29.10.2015 | Universal Health Services Equal Weight | Barclays Capital | |
03.08.2015 | Universal Health Services Equal Weight | Barclays Capital |
Datum | Rating | Analyst | |
---|---|---|---|
20.02.2007 | Universal Health underperform | Bear Stearns | |
31.08.2005 | Update Universal Health Services Inc.: Underperfor | Goldman Sachs | |
31.08.2005 | Universal Health underperform | Goldman Sachs | |
24.01.2005 | Update Universal Health Services Inc.: Reduce | UBS |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Universal Health Services Inc. nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen